In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients. The blood of recovered patients contains antibodies ...
Oct 16, 2020
0
49
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems. However, autopsy and other studies have also revealed that the infection ...
Jan 12, 2021
0
182
Emory microbiologists have detected "heteroresistance" to colistin, a last-resort antibiotic, in already highly resistant Klebsiella pneumoniae, a bacterium that causes blood, soft tissue and urinary tract infections.
Mar 6, 2018
0
434
An international team including scientists from Albert Einstein College of Medicine of Yeshiva University and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) has identified the molecular "lock" ...
May 26, 2015
0
216
Cow dung, widely used as a fuel and in rituals in India, is likely behind an epidemic of black fungus that killed or maimed thousands of patients treated in the country for COVID-19 in 2021, say medical researchers.
Apr 5, 2022
0
62
Methamphetamine is a highly addictive stimulant that has been around for a long time, creating multiple health issues for users.
Apr 26, 2023
0
9
(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.
Sep 18, 2018
1
198
By the time symptoms of sporadic Creutzfeldt-Jakob disease (sCJD) are typically discovered, death is looming and inevitable. But, in a new study, researchers at University of California San Diego School of Medicine with colleagues ...
Nov 20, 2018
0
208
HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the ...
Jul 8, 2015
0
49
Two new studies by scientists at Scripps Research are bringing Ebola virus's weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection—not ...
Sep 13, 2018
0
147
